MedElevator Войти в исследования
← Поиск публикаций

DOI 10.5152/eurasianjmed.2017.17010

Медицинская библиотека · The Eurasian journal of medicine · 2017

Inflammation and Oxidation Biomarkers in Patients with Cystic Fibrosis: The Influence of Azithromycin.

Olveira Casilda, Padilla Alicia, Dorado Antonio, Contreras Victoria, Garcia-Fuentes Eduardo, Rubio-Martin Elehazara, Porras Nuria, Doña Esperanza, Carmona Ana, Olveira Gabriel

СтатьяПеревод в очереди

Аннотация

OBJECTIVE

In addition to their antibiotic effect, macrolides appear to modulate the inflammatory response in cystic fibrosis (CF) and could influence oxidative stress. The objective of this study was to assess oxidation biomarkers and levels of inflammation and to determine whether there is an association between these parameters and the intake of macrolides.

MATERIALS AND

METHODS

The subjects included in this cross-sectional study were, on the one hand, clinically stable patients with CF and, on the other, healthy controls. The following serum and plasma inflammatory and oxidative stress biomarkers were measured: interleukin-6 (IL-6), reactive C protein (RCP), tumor necrosis alpha (TNF-α), glutathione peroxidase (GPx), total antioxidant capacity (TAC), catalase (CAT), and superoxide dismutase (SOD), together with markers of lipid peroxidation (8-isoprostanes and thiobarbituric acid reactive substances [TBARS]). Clinical, anthropometric, lung function, radiological, and analytical variables (albumin, prealbumin, vitamins, and zinc) were also recorded.

RESULTS

We studied 36 adults with CF and 41 controls. No differences were observed in age, gender, or anthropometric variables. The patients had significantly higher levels of IL-6, TNF-α, RCP, TBARS, and isoprostanes, and lower levels of SOD than the controls. Twenty-three of the patients were treated with azithromycin, and they had more severe clinical and radiological parameters than those who were not but nevertheless presented significantly lower levels of TNF-α. No differences were observed in the markers of oxidation.

CONCLUSION

Inflammation and oxidation biomarkers were increased in patients with CF compared with controls. The use of azithromycin was associated with reduced TNF-α levels and did not influence oxidation parameters.

Для цитирования: Olveira Casilda, Padilla Alicia, Dorado Antonio, Contreras Victoria, Garcia-Fuentes Eduardo, Rubio-Martin Elehazara, Porras Nuria, Doña Esperanza, Carmona Ana, Olveira Gabriel. Inflammation and Oxidation Biomarkers in Patients with Cystic Fibrosis: The Influence of Azithromycin.. The Eurasian journal of medicine. 2017. DOI: 10.5152/eurasianjmed.2017.17010.
Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.